Intranasal nalmefene drug device combination product
Active Definitive Contract Awarded Last action
- Contract number
- 75A50123C00068
- Awardee
-
Indivior Inc. UEI VLCNBHCXCCJ9
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $55,172,093
Award facts
- Opportunity
-
- Request for Information - Project NextGen: Potential Market Shaping Strategies for Vaccine Development Special Notice · 75A50123R00003 · Posted Jul 6, 2023
- Contract value 51% obligated
-
- $55,172,093.00 Current, with exercised options
- $107,372,093.00 Potential, with all options
- Completion date 31% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- North Chesterfield, Richmond, VA 23236, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $2,271,744 | |
| Exercise an Option | $8,700,000 | |
| Change Order | $629,996 | |
| Change Order | $2,490,536 | |
| Exercise an Option | $8,700,000 | |
| Original award | $32,379,817 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Indivior Inc. for an intranasal nalmefene drug-device combination product on September 27, 2023, with a ceiling value of $107.4 million and ultimate completion date of September 27, 2033.
The contract carries cost-plus-fixed-fee pricing and no set-aside. Place of performance is North Chesterfield, Richmond, VA. The originating opportunity was a special notice posted July 6, 2023, seeking market input on vaccine development strategies under Project NextGen, though the awarded scope reflects the intranasal nalmefene product for opioid overdose treatment.
In fiscal 2024, Indivior invoiced $4.5 million across 6.6 FTEs and 13,819 contractor hours, yielding a derived government-paid blended hourly rate of $326.95. The company maintained one subcontractor, with 83 percent of contractor hours subcontracted out.
Quick answers
Who was awarded contract 75A50123C00068?
75A50123C00068 was awarded to Indivior Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 27, 2023.
How much is contract 75A50123C00068 worth?
The government has obligated $55,172,093 on 75A50123C00068. Its potential value, with all options, is $107,372,093.
Was contract 75A50123C00068 competed?
The extent of competition for 75A50123C00068 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award